Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Bristol-Myers Squibb (5)
Poly-Med (4)
Angiotech International (4)
IPXMEDICAL, LLC (4)
Merrell Dow Pharmaceuticals (3)
Regents of the University of California, The (3)
NA (3)
Pfizer (2)
The Johns Hopkins University (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
Children's Medical Center (2)
Thomas Jefferson University (2)
Massachusetts Institute Of Technology (2)
Eisai Co. (2)
The United States of America as represented by the Department of Health (2)
Procter & Gamble (1)
Phanos Technologies (1)
ANGIODEVICE INTERNATIONAL (1)
Chimerix (1)
HOSTETLER, KARL Y. (1)
Tapestry Pharmaceuticals (1)
Chemex Pharmaceuticals (1)
Advanced cardiovascular Systems (1)
Celgene (1)
Matrix Pharmaceutical (1)
Vestar (1)
SPEED GEL (1)
Hospira (1)
AMO UPPSALA AB (1)
PG-TXL (1)
HOSTETLER FAMILY TRUST (1)
Montana State University (1)
Regents Of The University of Minnesota (1)
Rhone-Poulenc Rorer (1)
COVALON technology (1)
McGill University (1)
Vertex Pharmaceuticals (1)
COOK MEDICAL TECHNOLOGIES (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
Samyang (5)
ANGIODEVICE INTERNATIONAL (5)

Referenced by

Boston Scientific (38)
conextions (19)
CritiTech (18)
broncus medical (16)
Celgene (12)
dfb soria (7)
University of Utah (5)
resurge therapeutics (4)
SurModics (4)
SWEET, RICHARD M. (2)
COOK MEDICAL TECHNOLOGIES (2)
Industrial Technology research Institute (2)
Broncus Technologies (2)
Covidien (2)
Cardiac Pacemakers (2)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
Remon Medical Technologies (1)
Otago Innovation (1)
dfb soria ll (1)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
Abbott Laboratories (1)
critltech (1)
University of Kentucky Research Foundation (1)
Bristol-Myers Squibb (1)
Omeros (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7